Tag Archives: Fred Hassan

Fred Hassan: More Musings on the Biopharma Learning Curve

Hindsight can be a great teacher – but only if you have the self-awareness needed to adapt those learnings to the next business challenge, whose rough edges are by definition almost always “non-recurring.” In other words, because the circumstances of any setback are unique, the astute manager knows that recovery depends on recognizing that the […]
Posted in healthcare, leadership, People, R&D, Sales, Strategy | Also tagged , , , , | 2 Comments

One Company, One Defining Moment

Being an observer rather than a participant in the drugs business makes it easier to sense those defining moments when something fundamental has changed, a limit is reached, and a new order emerges to reset the basic license to operate.   As Pharm Exec monthly goes to press, one such moment appears to have arrived, with […]
Posted in Emerging Markets, Global, Strategy | Also tagged , , , , , , , | 1 Comment

Merck, Schering-Plough Merger Boosts Global Profile, but Questions Linger

Image via Wikipedia After Merck & Co. officially announced its $41.1 billion merger with Schering-Plough yesterday, CEO Richard Clark made it clear his company is still looking to expand through further acquisitions and mergers. According to the Wall Street Journal’s Health Blog: Clark told us today that the newly combined company  is “actively looking” for […]
Posted in Strategy | Also tagged , , , , , , | 2 Comments
  • Categories

  • Meta